François Herrmann

Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

G. Brittinger, D. Huhn, H. Gerhartz, 1984, Hematological oncology.

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

P Reichardt, R Gürtler, D. Huhn, 1996, Cancer research.

Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.

F. Herrmann, P. Robert, É. Liozon, 2001, The American journal of medicine.

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer.

R. Cheney, F. Herrmann, P. Mhawech-Fauceglia, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.

R. Mertelsmann, W. Oster, A. Lindemann, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate‐specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique

G. Sauter, L. Terracciano, P. Mhawech-Fauceglia, 2007, Histopathology.